We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$638M
AUM Growth
-$478M
Cap. Flow
-$481M
Cap. Flow %
-75.43%
Top 10 Hldgs %
26.77%
Holding
396
New
19
Increased
55
Reduced
247
Closed
70

Sector Composition

1 Healthcare 30.76%
2 Consumer Staples 20.45%
3 Technology 14.41%
4 Financials 10.29%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGA icon
76
Reinsurance Group of America
RGA
$15.7B
$1.51M 0.24%
7,349
+764
+12% +$153K
CAG icon
77
Conagra Brands
CAG
$6.92B
$1.5M 0.23%
52,697
-67,869
-56% -$2.04M
WPM icon
78
Wheaton Precious Metals
WPM
$47.3B
$1.49M 0.23%
20,807
-2,061
-9% -$110K
MRNA icon
79
Moderna
MRNA
$25.1B
$1.49M 0.23%
12,545
-55,983
-82% -$7.08M
CCJ icon
80
Cameco
CCJ
$38B
$1.47M 0.23%
21,820
+15,404
+240% +$781K
TSN icon
81
Tyson Foods
TSN
$20.4B
$1.46M 0.23%
25,565
+22,980
+889% +$1.34M
HPQ icon
82
HP
HPQ
$22.1B
$1.33M 0.21%
37,868
+32,346
+586% +$1.03M
FNV icon
83
Franco-Nevada
FNV
$38.2B
$1.31M 0.2%
8,052
+4,535
+129% +$551K
BIIB icon
84
Biogen
BIIB
$30.8B
$1.24M 0.19%
5,345
-4,818
-47% -$1.05M
SIRI icon
85
SiriusXM
SIRI
$10.5B
$1.14M 0.18%
40,316
-121,278
-75% -$3.62M
REGN icon
86
Regeneron Pharmaceuticals
REGN
$71.2B
$1.11M 0.17%
1,058
-2,517
-70% -$2.44M
PG icon
87
Procter & Gamble
PG
$353B
$1.1M 0.17%
6,660
-5,871
-47% -$960K
EPAM icon
88
EPAM Systems
EPAM
$4.58B
$1.06M 0.17%
5,662
-1,519
-21% -$324K
NDAQ icon
89
Nasdaq
NDAQ
$53.3B
$1.02M 0.16%
16,923
+15,221
+894% +$922K
V icon
90
Visa
V
$694B
$983K 0.15%
3,744
-586
-14% -$161K
CTSH icon
91
Cognizant
CTSH
$21.1B
$976K 0.15%
14,359
+12,163
+554% +$825K
AMD icon
92
Advanced Micro Devices
AMD
$817B
$972K 0.15%
5,991
-1,162
-16% -$187K
UNH icon
93
UnitedHealth
UNH
$384B
$963K 0.15%
1,891
-2,185
-54% -$1.07M
ERIE icon
94
Erie Indemnity
ERIE
$11.8B
$952K 0.15%
2,628
-7,644
-74% -$2.9M
BCE icon
95
BCE
BCE
$20.6B
$932K 0.15%
21,030
+8,266
+65% +$276K
RMD icon
96
ResMed
RMD
$29.4B
$890K 0.14%
4,651
+3,669
+374% +$744K
CF icon
97
CF Industries
CF
$18.2B
$889K 0.14%
11,998
-2,625
-18% -$204K
EXAS
98
DELISTED
Exact Sciences
EXAS
$843K 0.13%
+19,955
New +$1.1M
GILD icon
99
Gilead Sciences
GILD
$169B
$839K 0.13%
12,232
-14,132
-54% -$943K
MU icon
100
Micron Technology
MU
$964B
$779K 0.12%
5,919
+1,111
+23% +$140K

Similar funds

TOBAM's Q2 2024 Portfolio in Review

As of Q2 2024, TOBAM held 396 positions worth $638M, down 43% from $1.12B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM withdrew a net $481M in Q2 2024, closing 70 positions and reducing 247 holdings. Its most notable exit was Markel Group, an estimated $1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Globe Life worth $4.7M.

  • TOBAM's largest Q2 2024 buy was Globe Life: 57,069 shares worth $4.7M.
  • TOBAM added most to Jabil in Q2 2024, an estimated $6.21M increase.
  • TOBAM's biggest Q2 2024 reduction was Progressive, cutting an estimated $22M.
  • TOBAM fully exited Markel Group in Q2 2024, selling an estimated $1M.
  • TOBAM's ten largest holdings make up 27% of its $638M portfolio in Q2 2024.
  • TOBAM opened 19 new positions and closed 70 in Q2 2024.
  • TOBAM's portfolio value fell 43% quarter-over-quarter to $638M.

Based on TOBAM's 13F filing for Q2 2024, filed 29 Jul 2024.